Placeholder Banner

Biodefense: 2010 National Security Strategy

March 10, 2016

Time and again in our Nation's history, Americans have risen to meet -and to shape- moments of transition. This must be one of those moments. We live in a time of sweeping change. The success of free nations, open markets and social progress in recent decades have accelerated globalization on an unprecedented scale. This has opened the doors of opportunity around the globe, extended democracy to hundreds of millions of people and made peace possible among the major powers. Yet globalization has also intensified the dangers we face - from international terriorism and the spread of deadly technologies, to economic upheaveal and a changing climate.

Download Full Comments Below
National Security Strategy
Read the strategy
Discover More
To protect patient access to critical prescription drugs, BIO has identified Part D guardrails (both MA-PD and PDP) for consideration as CMS develops guidance to plans for CY2025 and beyond.
BIO joined other stakeholders to urge Congressional leaders to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA).
On behalf of CSBA, BIO submitted this MDRP sign-on letter to CMS, which strongly urged the agency to refrain from finalizing a proposal that would drastically impact the Medicaid Best Price calculation.